ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · BIOX

Atlas market file · Equity · United States

Bioceres Crop Solutions Corp.BIOX

Last close
0.36
Change
-1.10%
96-bar range
0.301 – 0.7
As of
6 Aug 2026

Bioceres Crop Solutions Corp. is an agricultural chemicals issuer listed as BIOX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:BIOX

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

0.711970.606230.50050.394760.2890320 Mar29 May06 Aug

up candle   down candle

Latest close0.36
Day change-1.10%
Window high0.7
Window low0.301
96-bar change-3.23%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (-96.38% over the window).

11.0524unknown19 Aug06 Aug

Source rail: Yahoo Finance chart API (BIOX). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for BIOX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

BIOX public profile

Company

Agricultural chemicals issuer. Bioceres Crop Solutions Corp. is connected to current market context, cited company sources and its retained research file.

Market

Bioceres Crop Solutions Corp. trades as BIOX on NASDAQ. Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BIOX under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Bioceres Crop Solutions Corp. has the awkward job of being more than BIOX, which is not always how markets behave. Bioceres Crop Solutions Corp. is listed on NASDAQ in United States with TradingView symbol NASDAQ:BIOX and public listing evidence. A ticker can reduce a whole business to a blinking square, but customers, products, margins, suppliers, regulation, capital, and cash still have to do the actual work. A listed company earns a wider paragraph through evidence, not adjectives, so the useful next step for BIOX is the specific filing, earnings line, or ownership change that turns today's outline into something a reader can check (source: public profile, https://atlas.freedomcore.io/stocks/BIOX/).

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Bioceres Crop Solutions Corp. today

Open full report
BIOX daily contextvalidated public digest5 source rail2026-08-07 02:40 UTC

Bioceres Crop Solutions Corp. reported total revenues of $39.4 million for the fiscal third quarter ended March 31, 2026-a 23% year-over-year decline driven by softer demand and competitive pressure in crop protection, plus the ongoing transition in its seeds business. The company, which styles itself as a leader in productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, posted a net loss of $10.0 million and adjusted EBITDA of negative $0.6 million in the same period.

The business sits at the intersection of ag-tech and climate narrative, selling products it claims reliably and cost-effectively support climate-smart practices while increasing yields and quality. Its flagship HB4 drought-tolerant wheat is approved in Argentina and Brazil, and the company publishes environmental assessments alongside its product pipeline, positioning itself as both an innovator and an emissions-conscious operator. Yet the headline numbers show a company struggling to translate its sustainability story into sales growth.

Filings detail a third-quarter loss of $10.0 million on revenues of $39.4 million, with adjusted EBITDA at negative $0.6 million. The company describes its mission as “making crops more resilient to climate change,” but the income statement reads like a stress test under real-world drought conditions. Management will host a results conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time; the original invite required correction, with the US toll-free number updated to 1-833-461-5787 and the conference ID revised to 717574163. The updated invite and product imagery are available on the investor site.

Investors can review the official product and sustainability pages for the company’s positioning and pipeline, while the financial press kit and multimedia assets outline its narrative. The sustainability page highlights efforts to reduce the GHG emissions footprint of operations even as it commercialises products aimed at climate-smart agriculture. The investor relations rail also includes the corrected conference call details and product imagery, which frame the company’s public messaging. For a closer look at the operating metrics and segment dynamics, the third-quarter results release is the primary source.

If you’re tracking this story for datapoints, the revenue decline and negative adjusted EBITDA are the two figures worth anchoring to. The rest of the narrative-regeneration, resilience, climate-smart-is marketing until the cash flow turns positive. The company’s own filings and product pages set the official story; the quarterly numbers set the reality. Until that changes, the gap between pitch and P&L remains the story to watch.

Sources & evidence · 5 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
BIOX
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

BIOX technical readout

Trend strength (ADX 14)
19.9
Average true range (ATR 14)
0.0349
ATR as % of price
10.80%
Volatility compression (ATR14/ATR50)
0.66x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

BIOX evidence rails

Atlas uses the specific public rails available for BIOX: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on BIOX

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for BIOX Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep BIOX research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

BIOX FAQ

What is Bioceres Crop Solutions Corp. (BIOX)?Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. Use this page to check the price chart, company context,...

Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for BIOX?Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...

Bioceres Crop Solutions Corp. (BIOX) has a latest verified close of 0.36, down 1.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BIOX under USA Stocks for browsing.

How often is the BIOX page updated?The BIOX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The BIOX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for BIOX?The BIOX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BIOX. SEC EDGAR provides the filing anchor for this issuer. The page separates...

The BIOX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BIOX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on BIOX?Yes. The workstation can open BIOX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open BIOX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this BIOX page investment advice?No. The BIOX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The BIOX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →